A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)

NCT00816712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscle Anabolism

Interventions

DRUG: Comparator: Testosterone 300 mg, intramuscular injection
DRUG: Comparator: Testosterone 100 mg, Intramuscular injection
DRUG: Comparator: Placebo given by Intramuscular Injection

Sponsor

Merck Sharp & Dohme LLC